Yahoo Finance

Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain

London, UK, 07 March 2024 – Persica Pharmaceuticals Ltd, a privately held, clinical stage pharmaceutical company developing an antibiotic formulation for intradiscal injection to treat Chronic Low ...
Yahoo Finance

Persica Pharmaceuticals' Positive Clinical Data for PP353 Treatment of Chronic Low Back Pain Published in The Lancet's eClinicalMedicine

Trial demonstrated that PP353 delivers clinically meaningful and durable reduction in pain and disability in patients with chronic Low Back Pain and Modic Type 1 changes PP353 has the potential to ...
BMJ

Antibiotic treatment in patients with low-back pain associated with Modic changes Type 1 (bone oedema): a pilot study

Objective: The aim of this study was to assess the clinical effect of antibiotic treatment in a cohort of patients with low-back pain (LBP) and Modic changes Type 1 (bone oedema) following a lumbar ...
Healio

Patients with type 1 Modic changes can be at risk for no improvement

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Researchers found sick-listed low back ...
Mena FN

Persica Pharmaceuticals Completes Recruitment Into Modic Trial Assessing Efficacy Of PP353, To Treat Chronic Lower Back Pain

(MENAFN- GlobeNewsWire - Nasdaq) Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain London, UK, 07 March 2024 – Persica ...